Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
World Journal of Surgery
Published in: World Journal of Surgery 8/2017

01-08-2017 | Original Scientific Report

Risk Factors for Postoperative Ascites in Patients Undergoing Liver Resection for Hepatocellular Carcinoma

Authors: Takahiro Yoshikawa, Takeo Nomi, Daisuke Hokuto, Satoshi Yasuda, Chihiro Kawaguchi, Takatsugu Yamada, Hiromichi Kanehiro, Yoshiyuki Nakajima

Published in: World Journal of Surgery | Issue 8/2017

Login to get access

Abstract

Background

Postoperative ascites is a common complication after liver resection. This study aimed to identify the risk factors for ascites in patients after liver resection and the relationship between postoperative ascites and other complications.

Methods

We retrospectively analyzed data that were obtained from 266 patients who underwent liver resection for treating hepatocellular carcinoma between 2008 and 2015. Postoperative ascites was defined as a daily ascitic fluid drainage exceeding 500 mL on postoperative day 3 or later. The participants were categorized and analyzed with respect to the presence or absence of postoperative ascites.

Results

Overall, 17 (6.4%) patients developed postoperative ascites. A multivariate analysis identified that three significant factors—serum albumin, platelet count, and operation duration—were associated with the development of postoperative ascites. Sixteen (94.1%) of the 17 patients with postoperative ascites experienced other associated complications. The patients with ascites had more pleural effusion (70.6 vs. 17.7%, P < 0.001) than the patients without ascites. Postoperative morbidity, except for pleural effusion, was similar between the groups. The postoperative hospital stay duration was significantly longer in patients with ascites than in those without ascites.

Conclusions

Postoperative ascites frequently occurred in patients with decreased liver functional reserve. Moreover, the presence of ascites was associated with significantly increased pleural effusion rates, and postoperative hospital stay duration was significantly prolonged.
Literature
1.
2.
Kusano T, Sasaki A, Kai S et al (2009) Predictors and prognostic significance of operative complications in patients with hepatocellular carcinoma who underwent hepatic resection. Eur J Surg Oncol 35:1179–1185CrossRefPubMed
3.
Lv Y, Liu C, Wei T et al (2015) Cigarette smoking increases risk of early morbidity after hepatic resection in patients with hepatocellular carcinoma. Eur J Surg Oncol 41:513–519CrossRefPubMed
4.
Fong Y, Sun RL, Jarnagin W et al (1999) An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 229:790 discussion, 799–800 CrossRefPubMedPubMedCentral
5.
Capussotti L, Muratore A, Amisano M et al (2005) Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival—a European single center experience. Eur J Surg Oncol 31:986–993CrossRefPubMed
6.
7.
Salerno F, Borroni G, Moser P et al (1993) Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients. Am J Gastroenterol 88:514–519PubMed
8.
Rimola A, García-Tsao G, Navasa M et al (2000) Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. Int Ascites Club J Hepatol 32:142–153
9.
10.
Ishizawa T, Hasegawa K, Kokudo N et al (2009) Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma. Arch Surg 144:46–51CrossRefPubMed
11.
Chen LP, Li C, Wang C et al (2012) Risk factors of ascites after hepatectomy for patients with hepatocellular carcinoma and hepatitis B virus-associated cirrhosis. Hepatogastroenterology 59:292–295CrossRefPubMed
12.
Arroyo V, Ginès P, Gerbes AL et al (1996) Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Int Ascites Club Hepatology 23:164–176
13.
Ginès P, Cárdenas A, Arroyo V et al (2004) Management of cirrhosis and ascites. N Engl J Med 350:1646–1654CrossRefPubMed
14.
Moore KP, Wong F, Gines P et al (2003) The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 38(1):258–266CrossRefPubMed
15.
Morise Z, Ciria R, Cherqui D et al (2015) Can we expand the indications for laparoscopic liver resection? A systematic review and meta-analysis of laparoscopic liver resection for patients with hepatocellular carcinoma and chronic liver disease. J Hepatobiliary Pancreat Sci 22:342–352CrossRefPubMed
16.
Kanazawa A, Tsukamoto T, Shimizu S et al (2013) Impact of laparoscopic liver resection for hepatocellular carcinoma with F4-liver cirrhosis. Surg Endosc 27:2592–2597CrossRefPubMed
17.
18.
Belli G, Fantini C, D’Agostino A et al (2007) Laparoscopic versus open liver resection for hepatocellular carcinoma in patients with histologically proven cirrhosis: short- and middle-term results. Surg Endosc 21:2004–2011CrossRefPubMed
19.
Li N, Lai EC, Shi J et al (2010) A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection. Ann Surg Oncol 17:179–185CrossRefPubMed
20.
Wong JS, Wong GL, Tsoi KK et al (2011) Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma. Aliment Pharmacol Ther 33:1104–1112CrossRefPubMed
21.
Okabayashi T, Nishimori I, Sugimoto T et al (2008) Effects of branched-chain amino acids-enriched nutrient support for patients undergoing liver resection for hepatocellular carcinoma. J Gastroenterol Hepatol 23:1869–1873CrossRefPubMed
22.
Muto Y, Sato S, Watanabe A et al (2005) Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 3:705–713CrossRefPubMed
23.
24.
Tamano M, Hashimoto T, Kojima K et al (2010) Diagnosis of hepatic hydrothorax using contrast-enhanced ultrasonography with intraperitoneal injection of Sonazoid. J Gastroenterol Hepatol 25:383–386CrossRefPubMed
25.
Ajmi S, Sfar R, Nouira M et al (2008) Role of the peritoneopleural pressure gradient in the genesis of hepatic hydrothorax. Isot Gastroenterol Clin Biol 32:729–733CrossRef
Metadata
Title
Risk Factors for Postoperative Ascites in Patients Undergoing Liver Resection for Hepatocellular Carcinoma
Authors
Takahiro Yoshikawa
Takeo Nomi
Daisuke Hokuto
Satoshi Yasuda
Chihiro Kawaguchi
Takatsugu Yamada
Hiromichi Kanehiro
Yoshiyuki Nakajima
Publication date
01-08-2017
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 8/2017
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-017-4003-x

Other articles of this Issue 8/2017

World Journal of Surgery 8/2017 Go to the issue

Original Scientific Report

A Population-Based Cohort Study of Emergency Appendectomy Performed in England and New York State

Original Scientific Report

Laparoscopic Repair of Duodenal Atresia: Systematic Review and Meta-Analysis

Original Scientific Report

Trends in Procedures at Major Trauma Centres in New South Wales, Australia: An Analysis of State-Wide Trauma Data

Original Scientific Report

Major Complex Abdominal Wall Repair in Contaminated Fields with Use of a Non-cross-linked Biologic Mesh: A Dual-Institutional Experience

Original Scientific Report

Patient Self-Assessment of Surgical Site Infection is Inaccurate

Original Scientific Report

Preoperative Plasma Fibrinogen is Associated with Lymph Node Metastasis and Predicts Prognosis in Resectable Esophageal Cancer